Pdp1 (923)
Amlodipine And Olmesartan Medoxomil
Product Images NDC 45865-935
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine And Olmesartan Medoxomil (NDC 45865-935). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Pdp2 (935)
Amlodipine.jpg (Amlodipine)
Figure1.jpg (Figure1)
The text given is displaying blood pressure readings in mmHg units. It states that SBP (systolic blood pressure) should be less than 140 mmHg. The rest of the text appears to be unclear as it contains errors and no useful information can be extracted from it.*
Figure2.jpg (Figure2)
The blood pressure measurement of D8P is less than 90 mmHg. The rest of the text is not clear and does not provide any additional useful information.*
Figure3.jpg (Figure3)
This text provides information related to a medical trial or study where SBP (systolic blood pressure) is being measured. The goal is to keep SBP below 130 mmHg. There is also a reference to a medication called "detekPlacebo" with a dosage of "A42AMLI0 mg." The numbers at the bottom appear to be a baseline measurement of SBP ranging from 145 to 165 mmHg. However, the context of the text is not fully clear.*
Figure4.jpg (Figure4)
This appears to be a blood pressure reading with a baseline diastolic blood pressure (DBP) reading of less than 80 mmHg. The other numbers and text seem to be unrelated or possibly corrupted .*
Olmesartanmedoxomil.jpg (Olmesartanmedoxomil)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
